# Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.

> **NCT06291883** · PHASE1 · COMPLETED · sponsor: **Sheng-Teng Huang** · enrollment: 26 (actual)

## Conditions studied

- Coronavirus Disease 2019
- Severe Acute Respiratory Syndrome Coronavirus 2 Infection

## Interventions

- **COMBINATION_PRODUCT:** Kang Guan Recipe (Treat)
- **COMBINATION_PRODUCT:** Kang Guan Recipe (Placebo)

## Key facts

- **NCT ID:** NCT06291883
- **Lead sponsor:** Sheng-Teng Huang
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-09
- **Primary completion:** 2023-04-18
- **Final completion:** 2024-02-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06291883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06291883, "Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06291883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*